Description
CJC-1295 (No DAC) + Ipamorelin (Research Use Only)
CJC-1295 (No DAC) and Ipamorelin are two well-known research peptides commonly studied together for their complementary roles in growth hormone-related pathways. This combination has gained significant attention within the research community due to its ability to provide a more controlled and structured approach when exploring signalling patterns linked to metabolism, body composition, and recovery processes.
CJC-1295 (No DAC) is a short-acting peptide studied for its role in stimulating growth hormone release in a pulsatile manner. Unlike its DAC counterpart, it is designed for shorter activity, making it particularly relevant in research focused on natural-like signalling patterns and timing-based protocols.
Ipamorelin is a selective peptide known for its targeted mechanism, stimulating growth hormone release without significantly impacting other pathways. Its clean and focused profile makes it a valuable compound in studies exploring metabolic function, body composition, and recovery-related pathways.
Researchers are particularly interested in this combination for its potential to:
Support studies related to growth hormone signalling patterns
Assist in research on body composition and metabolic function
Explore pulse-based activity in controlled research settings
Provide a structured approach to studying hormone-related pathways
The pairing of these two peptides allows for a complementary research model, with both compounds working within the same pathway while maintaining a controlled and targeted activity profile.
Each vial is manufactured to a high purity standard (≥99.5%), ensuring consistency and reliability for laboratory research purposes.
Supplied with BAC Water for reconstitution.
Important Notice:
This product is intended strictly for laboratory research purposes only. Not for human consumption, medical, or diagnostic use.



